BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33253711)

  • 1. FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway.
    Zou Y; Du Y; Cheng C; Deng X; Shi Z; Lu X; Hu H; Qiu J; Jiang W
    Exp Cell Res; 2021 Jan; 398(1):112401. PubMed ID: 33253711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
    Dong D; Jiang W; Lei J; Chen L; Liu X; Ge J; Che B; Xi X; Shao J
    Oncotarget; 2016 Dec; 7(49):81463-81473. PubMed ID: 27806337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.
    Liu L; Dong Z; Liang J; Cao C; Sun J; Ding Y; Wu D
    Oncogene; 2014 Feb; 33(7):909-20. PubMed ID: 23812429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
    Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
    Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
    Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
    Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation.
    Li H; Lu S; Chen Y; Zheng L; Chen L; Ding H; Ding J; Lou D; Liu F; Zheng B
    Cell Signal; 2019 Jun; 58():99-110. PubMed ID: 30877036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway.
    Liu S; Chen Q; Wang Y
    Hum Cell; 2020 Jan; 33(1):185-194. PubMed ID: 31605287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-like protein FAT10 promotes osteosarcoma growth by modifying the ubiquitination and degradation of YAP1.
    Yi X; Deng X; Zhao Y; Deng B; Deng J; Fan H; Du Y; Hao L
    Exp Cell Res; 2020 Feb; 387(2):111804. PubMed ID: 31877302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
    Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
    Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
    Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
    Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.
    Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y
    Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human HLA‑F adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.
    Li C; Wang Z; Feng N; Dong J; Deng X; Yue Y; Guo Y; Hou J
    Mol Med Rep; 2018 Jul; 18(1):308-314. PubMed ID: 29749526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
    Xie X; Li H; Pan J; Han X
    Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
    Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
    Molecules; 2019 May; 24(10):. PubMed ID: 31137633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-Like Protein FAT10 Promote Colorectal Cancer Progression by Affecting the Ubiquitination of Capn4.
    Cheng F; Yuan L; Wu Z; Li X; Xia W; Huang Z; Li Z; Mao S; Shen W
    Dig Dis Sci; 2023 Aug; 68(8):3312-3323. PubMed ID: 37310562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
    Li Z; Hong S; Liu Z
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway.
    Luo C; Xiong H; Chen L; Liu X; Zou S; Guan J; Wang K
    Exp Cell Res; 2018 Apr; 365(1):1-11. PubMed ID: 29458176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1.
    Tong ZT; Wei JH; Zhang JX; Liang CZ; Liao B; Lu J; Fan S; Chen ZH; Zhang F; Ma HH; Qian WC; Kong LL; Fang Y; Chen W; Xie D; Luo JH
    Br J Cancer; 2013 Apr; 108(7):1470-9. PubMed ID: 23511556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.